Empaveli (pegcetacoplan) prior authorization denied appeal
Complement inhibitor for PNH
Typical PA criteria
- PNH diagnosis
- Specialist prescriber
- Meningococcal vaccination
Why your PA was denied
- Vaccination not documented
- Specialist criteria not met
Evidence that overturns the denial
- ✓Flow cytometry confirming PNH
- ✓Vaccination record
- ✓Hematologist letter
Rare-disease drug; appeals usually succeed when documentation is complete.
Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.
FAQ
Why was my Empaveli (pegcetacoplan) prior authorization denied?+
The most common reasons are: Vaccination not documented; Specialist criteria not met. Your denial letter names the specific criteria you did not meet.
How do I appeal a Empaveli (pegcetacoplan) denial?+
File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.
What evidence overturns a Empaveli (pegcetacoplan) denial?+
Flow cytometry confirming PNH; Vaccination record; Hematologist letter.
What if the plan excludes Empaveli (pegcetacoplan) entirely?+
Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.
Other drugs
- Wegovy (semaglutide)
- Zepbound (tirzepatide)
- Ozempic (semaglutide)
- Mounjaro (tirzepatide)
- Saxenda (liraglutide)